Back
BioXcel Therapeutics Vs. Merck & Industry Stock Comparison
Sell
30
BTAI
BioXcel Therapeutics
Last Price:
2.97
Seasonality Move:
13.65%
Buy
53
MRK
Merck &
Last Price:
126.89
Seasonality Move:
2.29%
Sell
30
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy, Sell or Hold?
- The current BioXcel Therapeutics [BTAI] share price is $2.84. The Score for BTAI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Merck & (MRK)
is a Buy
Is Merck & a Buy, Sell or Hold?
- The current Merck & [MRK] share price is $126.94. The Score for MRK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- MRK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BTAI Stock Price Chart
What is BioXcel Therapeutics's stock price today?
-
The BioXcel Therapeutics share price today is $2.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BTAI is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRK Stock Price Chart
BTAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 53.1 | Buy |
| Chaikin Money Flow: | 316385 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.64 - 2.84) | Buy |
| Bollinger Bands (100): | (2.62 - 3.42) | Sell |
MRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 54.02 | Buy |
| Chaikin Money Flow: | -1758376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (123.81 - 129.21) | Buy |
| Bollinger Bands (100): | (111.05 - 128.47) | Buy |
BTAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.74 | Buy |
| 20-day SMA: | 2.73 | Buy |
| 50-day SMA: | 2.87 | Sell |
| 200-day SMA: | 4.06 | Sell |
| 8-day EMA: | 2.72 | Buy |
| 20-day EMA: | 2.74 | Buy |
| 50-day EMA: | 2.87 | Sell |
| 200-day EMA: | 5.71 | Sell |
MRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.81 | Buy |
| 20-day SMA: | 127.4 | Sell |
| 50-day SMA: | 126.03 | Buy |
| 200-day SMA: | 112.71 | Buy |
| 8-day EMA: | 126.13 | Buy |
| 20-day EMA: | 126.28 | Buy |
| 50-day EMA: | 124.77 | Buy |
| 200-day EMA: | 115.81 | Buy |
BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.29 per share.
Merck & Earnings Growth & MRK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.04 per share, an increase this year of $7.19 per share, and an increase next year of $1.26 per share.
BioXcel Therapeutics Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merck & Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||